Case Report: Treatment of porphyria cutanea tarda with low dose hydroxychloroquine [version 1; peer review: 1 approved, 2 approved with reservations]

oleh: Alexander Nirenberg, Andrew Awad, Rodney Sinclair

Format: Article
Diterbitkan: F1000 Research Ltd 2022-08-01

Deskripsi

Background: Porphyria cutanea tarda (PCT) is a complex metabolic disease resulting from altered activity of the enzyme uroporphyrinogen decarboxylase (UROD) in the liver resulting in accumulation of uroporphyrin. PCT presents as a blistering photodermatitis with skin fragility, vesicles, scarring and milia. Case: We report a case of PCT in a 67-year-old man with hemochromatosis (HFE) gene mutation who, following a major syncopal episode in response to venesection was commenced on low dose hydroxychloroquine. Conclusions: Low dose hydroxychloroquine provided a safe and effective alternative to venesection in this patient who was needle phobic.